title: Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.
abstract: More than 100 drugs are used to treat the many different cancers. They can be divided into agents with relatively broad, non-targeted specificity and targeted drugs developed on the basis of a more refined understanding of individual cancers and directed at specific molecular targets on different cancer cells. Individual drugs in both groups have been classified on the basis of their mechanism of action in killing cancer cells. The targeted drugs include proteasome inhibitors, toxic chimeric proteins and signal transduction inhibitors such as tyrosine kinase (non-receptor and receptor), serine/threonine kinase, histone deacetylase and mammalian target of rapamycin inhibitors. Increasingly used targeted vascular (VEGF) and platelet-derived endothelial growth factor blockade can provoke a range of pathological consequences. Many of the non-targeted drugs are cytotoxic, suppressing haematopoiesis as well as provoking cutaneous eruptions and vascular, lung and liver injury. Cytotoxic side effects of the targeted drugs occur less often and usually with less severity, but they show their own unusual adverse effects including, for example, a lengthened QT interval, a characteristic papulopustular rash, nail disorders and a hand-foot skin reaction variant. The term hypersensitivity is widely used across a number of disciplines but not always with the same definition in mind, and the terminology needs to be standardised. This is particularly apparent in cancer chemotherapy where anti-neoplastic drug-induced thrombocytopenia, neutropenia, anaemia, vascular disorders, liver injury and lung disease as well as many dermatological manifestations sometimes have an immune basis. The most insidious of all adverse consequences of targeted therapies, however, are tumour adaptation, increased malignancy and the invasive metastatic switch seen with anti-angiogenic drugs that inhibit the VEGF-A pathway. Adverse reactions to 44 non-targeted and 33 targeted, frequently used, chemotherapeutic drugs are presented together with discussions of diagnosis, premedications, desensitizations and importance of understanding the mechanisms underlying the various drug-induced reactions. There is need for wide-ranging acceptance of what constitutes a hypersensitivity reaction and for allergists to be more involved in the diagnosis, treatment and prevention of chemotherapeutic drug-induced hypersensitivity reactions.
authors.affiliation: Molecular Immunology Unit, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, Sydney, New South Wales, Australia, babaldo@iinet.net.au.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Baldo
authors.forename: Nghia H
authors.initials: NH
authors.lastname: Pham
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D011292:Premedication; D047368:Tumor Burden; D015275:Tumor Lysis Syndrome / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D016207:Cytokines
references.citation: Nat Rev Cancer. 2003 Oct;3(10):721-32
references.pmid: 13130303
references.citation: Ann Intern Med. 1981 Jan;94(1):66-72
references.pmid: 7004302
references.citation: Cancer Res. 2011 Sep 1;71(17):5626-34
references.pmid: 21795476
references.citation: J Dermatol. 1995 Feb;22(2):116-21
references.pmid: 7722086
references.citation: J Hematol Oncol. 2010 Mar 26;3:12
references.pmid: 20346128
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:513-39
references.pmid: 16879083
references.citation: Expert Opin Pharmacother. 2010 Jul;11(10):1705-14
references.pmid: 20509772
references.citation: Expert Opin Investig Drugs. 2011 Jun;20(6):733-44
references.pmid: 21457108
references.citation: Int Arch Allergy Immunol. 2008;145(1):54-7
references.pmid: 17703101
references.citation: Eur J Haematol. 2002 Nov-Dec;69(5-6):315-7
references.pmid: 12460237
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):971-9
references.pmid: 16002463
references.citation: Curr Cancer Drug Targets. 2003 Dec;3(6):391-405
references.pmid: 14683498
references.citation: Clin Lab Haematol. 2000 Jun;22(3):175-8
references.pmid: 10931169
references.citation: J Investig Allergol Clin Immunol. 2012;22(6):448-9
references.pmid: 23101195
references.citation: Ann Oncol. 1998 Apr;9(4):453-5
references.pmid: 9636839
references.citation: Cancer Metastasis Rev. 2001;20(1-2):79-86
references.pmid: 11831651
references.citation: Respir Res. 2012 May 31;13:39
references.pmid: 22651223
references.citation: Acta Neuropathol. 2012 Dec;124(6):763-75
references.pmid: 23143192
references.citation: Ann Oncol. 1995 Mar;6(3):300-1
references.pmid: 7612497
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17069-74
references.pmid: 17942672
references.citation: Cancer Cell. 2009 Mar 3;15(3):232-9
references.pmid: 19249681
references.citation: Med J Aust. 1988 Jul 4;149(1):34-8
references.pmid: 3290635
references.citation: Hematol Cell Ther. 1998 Jun;40(3):113-8
references.pmid: 9698219
references.citation: J Clin Oncol. 2007 Oct 20;25(30):4722-9
references.pmid: 17947719
references.citation: Med Clin North Am. 2010 Jul;94(4):835-52, xiii
references.pmid: 20609866
references.citation: Am J Dermatopathol. 1997 Feb;19(1):73-8
references.pmid: 9056658
references.citation: Cancer. 1993 Feb 1;71(3):851-4
references.pmid: 8431868
references.citation: Acta Derm Venereol. 2010;90(1):73-6
references.pmid: 20107730
references.citation: Ann Oncol. 2003 Sep;14(9):1430-7
references.pmid: 12954584
references.citation: Lung Cancer. 2006 Feb;51(2):247-9
references.pmid: 16360237
references.citation: Br J Cancer. 2007 Jun 18;96(12):1788-95
references.pmid: 17519900
references.citation: Ann Intern Med. 1990 Jun 15;112(12):965-6
references.pmid: 2140253
references.citation: Drugs. 2009;69(7):889-918
references.pmid: 19441873
references.citation: Cancer Res. 2011 Jul 15;71(14):4758-68
references.pmid: 21613405
references.citation: Clin Cancer Res. 2011 Oct 15;17(20):6574-81
references.pmid: 21880788
references.citation: Dermatol Online J. 2009 Jul 15;15(7):14
references.pmid: 19903442
references.citation: Cancer Res. 2012 Nov 1;72(21):5588-99
references.pmid: 23118055
references.citation: Yonsei Med J. 2009 Dec 31;50(6):796-802
references.pmid: 20046420
references.citation: Circulation. 2012 May 1;125(17):2128-37
references.pmid: 22451584
references.citation: Rev Mal Respir. 2007 May;24(5):635-8
references.pmid: 17519817
references.citation: J Clin Invest. 2009 Apr;119(4):865-75
references.pmid: 19307731
references.citation: Aust N Z J Med. 1989 Feb;19(1):55-7
references.pmid: 2764806
references.citation: J Clin Oncol. 2012 Feb 1;30(4):441-4
references.pmid: 22184396
references.citation: Anticancer Res. 2004 Mar-Apr;24(2C):1267-9
references.pmid: 15154658
references.citation: Cancer Chemother Pharmacol. 2010 Apr;65(5):833-8
references.pmid: 19672598
references.citation: Leuk Lymphoma. 2004 Apr;45(4):811-3
references.pmid: 15160961
references.citation: Clin Rev Allergy. 1991 Fall-Winter;9(3-4):309-18
references.pmid: 1723653
references.citation: Blood. 2008 Dec 15;112(13):4808-17
references.pmid: 19064740
references.citation: Front Pharmacol. 2013 Apr 30;4:56
references.pmid: 23641216
references.citation: J Clin Oncol. 1997 Mar;15(3):1080-6
references.pmid: 9060548
references.citation: Transfusion. 1996 Nov-Dec;36(11-12):1016-8
references.pmid: 8937414
references.citation: Ann Clin Lab Sci. 2004 Spring;34(2):131-7
references.pmid: 15228223
references.citation: Eur J Cancer. 1998 Jul;34(8):1220-3
references.pmid: 9849483
references.citation: Blut. 1983 Mar;46(3):165-9
references.pmid: 6186321
references.citation: J Pediatr Hematol Oncol. 2001 Jan;23(1):73-4
references.pmid: 11196280
references.citation: Oncology. 2003;65 Suppl 2:7-10
references.pmid: 14586140
references.citation: Blood Rev. 2010 Jul-Sep;24(4-5):143-50
references.pmid: 20650555
references.citation: J Allergy Clin Immunol. 2004 May;113(5):832-6
references.pmid: 15131563
references.citation: Acta Oncol. 2001;40(7):882-3
references.pmid: 11859992
references.citation: Clin Transl Allergy. 2013 Feb 04;3(1):5
references.pmid: 23374544
references.citation: Nat Rev Drug Discov. 2003 Oct;2(10):803-11
references.pmid: 14526383
references.citation: J Clin Oncol. 1998 May;16(5):1885-9
references.pmid: 9586905
references.citation: Anticancer Drugs. 2004 Jul;15(6):581-5
references.pmid: 15205600
references.citation: N Engl J Med. 2002 Feb 28;346(9):645-52
references.pmid: 11870241
references.citation: Ann Oncol. 2006 Sep;17 Suppl 10:x85-9
references.pmid: 17018758
references.citation: J Clin Oncol. 2006 Jul 20;24(21):3504-5
references.pmid: 16849770
references.citation: Cancer Chemother Pharmacol. 1989;23(3):173-5
references.pmid: 2784360
references.citation: Oncologist. 2005 Oct;10(9):695-7
references.pmid: 16249348
references.citation: Yonsei Med J. 2007 Jun 30;48(3):421-4
references.pmid: 17594149
references.citation: Int Arch Allergy Appl Immunol. 1971;40(3):463-9
references.pmid: 4993767
references.citation: Pediatr Res. 1985 Apr;19(4):400-8
references.pmid: 3858789
references.citation: Neth J Med. 2012 Jan;70(1):12-7
references.pmid: 22271809
references.citation: Cancer Cell. 2010 Aug 9;18(2):171-84
references.pmid: 20708158
references.citation: Lancet. 2013 Jan 26;381(9863):303-12
references.pmid: 23177514
references.citation: Cancer. 2004 Jan 15;100(2):228-37
references.pmid: 14716755
references.citation: Adv Cancer Res. 2012;114:59-85
references.pmid: 22588056
references.citation: Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):394-400
references.pmid: 12023144
references.citation: Arch Pathol Lab Med. 2009 Feb;133(2):309-14
references.pmid: 19195976
references.citation: Curr Opin Allergy Clin Immunol. 2006 Aug;6(4):258-65
references.pmid: 16825865
references.citation: N Engl J Med. 1980 Feb 7;302(6):334-5
references.pmid: 7188625
references.citation: Semin Oncol. 1998 Feb;25(1):80-97
references.pmid: 9482530
references.citation: Nat Rev Cancer. 2002 Jan;2(1):38-47
references.pmid: 11902584
references.citation: Oncologist. 2005 Mar;10(3):176-82
references.pmid: 15793220
references.citation: Ann Dermatol Venereol. 2009 May;136(5):438-42
references.pmid: 19442802
references.citation: Clin Immunol. 2008 Oct;129(1):3-9
references.pmid: 18640073
references.citation: Science. 2005 Jan 7;307(5706):58-62
references.pmid: 15637262
references.citation: Clin Lymphoma. 2001 Mar;1(4):298-302
references.pmid: 11707845
references.citation: J Am Chem Soc. 2013 Jul 17;135(28):10418-25
references.pmid: 23796364
references.citation: J Hematol Oncol. 2010 Feb 04;3:5
references.pmid: 20132536
references.citation: Mol Aspects Med. 2010 Aug;31(4):287-329
references.pmid: 20451549
references.citation: J Am Acad Dermatol. 2006 Nov;55(5):897-900
references.pmid: 17052502
references.citation: Cancer. 1981 Oct 15;48(8):1738-45
references.pmid: 7284973
references.citation: Nat Rev Cancer. 2008 Aug;8(8):592-603
references.pmid: 18650835
references.citation: Cancer Metastasis Rev. 1987;6(3):413-32
references.pmid: 3319275
references.citation: N Engl J Med. 2007 Aug 9;357(6):580-7
references.pmid: 17687133
references.citation: Am J Hematol. 2006 Mar;81(3):193-8
references.pmid: 16493620
references.citation: Nihon Kokyuki Gakkai Zasshi. 2011 Sep;49(9):663-6
references.pmid: 22073612
references.citation: Nat Rev Clin Oncol. 2012 Apr 24;9(7):378-90
references.pmid: 22525710
references.citation: Cancer. 1986 Oct 1;58(7):1428-36
references.pmid: 3091244
references.citation: Arch Dermatol. 1999 Nov;135(11):1349-53
references.pmid: 10566833
references.citation: Lancet. 1986 Jun 21;1(8495):1439
references.pmid: 2872535
references.citation: J Clin Oncol. 2010 Jan 10;28(2):207-14
references.pmid: 19949018
references.citation: Cancer Cell. 2009 Mar 3;15(3):220-31
references.pmid: 19249680
references.citation: AJR Am J Roentgenol. 2001 Mar;176(3):718-20
references.pmid: 11222212
references.citation: Ann Oncol. 2001 Jan;12(1):132-3
references.pmid: 11249043
references.citation: Mol Pharmacol. 2005 Oct;68(4):917-32
references.pmid: 15955865
references.citation: Br J Cancer. 2011 Jan 4;104(1):166-74
references.pmid: 21119667
references.citation: Br J Dermatol. 2009 Nov;161(5):1045-51
references.pmid: 19558553
references.citation: Nat Clin Pract Oncol. 2006 Aug;3(8):448-57
references.pmid: 16894390
references.citation: Eur J Anaesthesiol. 1994 Jul;11(4):263-84
references.pmid: 7925333
references.citation: Eur Respir J. 2009 Apr;33(4):931-4
references.pmid: 19336595
references.citation: Allergy. 2009 Feb;64(2):234-41
references.pmid: 19178403
references.citation: Onkologie. 2010;33(5):249-52
references.pmid: 20502059
references.citation: Semin Oncol. 1997 Jun;24(3):334-59
references.pmid: 9208889
references.citation: Expert Rev Anticancer Ther. 2004 Feb;4(1):37-48
references.pmid: 14748655
references.citation: J Am Acad Dermatol. 1999 Mar;40(3):367-98; quiz 399-400
references.pmid: 10071309
references.citation: J Clin Invest. 2009 Nov;119(11):3356-72
references.pmid: 19809158
references.citation: Cancer Treat Rep. 1979 Mar;63(3):399-403
references.pmid: 427822
references.citation: Ann Allergy Asthma Immunol. 2006 Aug;97(2):216-22
references.pmid: 16937754
references.citation: Br Med J. 1973 Jan 6;1(5844):13-4
references.pmid: 4567104
references.citation: Expert Rev Anticancer Ther. 2007 Jan;7(1):11-7
references.pmid: 17187516
references.citation: World Health Organ Tech Rep Ser. 1972;498:1-25
references.pmid: 4625548
references.citation: Am Rev Respir Dis. 1989 Jan;139(1):18-21
references.pmid: 2521438
references.citation: Ann Rheum Dis. 2005 Apr;64(4):651-2
references.pmid: 15769928
references.citation: Eur J Haematol. 1997 Feb;58(2):109-13
references.pmid: 9111592
references.citation: Med Pediatr Oncol. 1981;9(3):257-64
references.pmid: 6941069
references.citation: Cancer Metastasis Rev. 2007 Jun;26(2):223-4
references.pmid: 17404692
references.citation: J Investig Allergol Clin Immunol. 2011;21(2):108-12
references.pmid: 21462800
references.citation: Clin Pharmacol Ther. 1976 Nov;20(5):611-6
references.pmid: 135667
references.citation: Eur J Med Res. 2012 Feb 23;17:4
references.pmid: 22472354
references.citation: Drug Resist Updat. 2009 Jun;12(3):74-80
references.pmid: 19394890
references.citation: J Am Acad Dermatol. 2008 Apr;58(4):545-70
references.pmid: 18342708
references.citation: Br J Haematol. 1989 Jun;72(2):127-32
references.pmid: 2788011
references.citation: J Intern Med. 1992 Aug;232(2):133-8
references.pmid: 1506809
references.citation: Clin Exp Allergy. 2011 Dec;41(12):1679-89
references.pmid: 21883538
references.citation: J Thromb Haemost. 2012 Apr;10(4):695-7
references.pmid: 22332994
references.citation: Arch Dermatol. 1999 Jul;135(7):818-20
references.pmid: 10411157
references.citation: J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):26-33
references.pmid: 8568134
references.citation: J Thorac Dis. 2013 Apr;5(2):E53-7
references.pmid: 23585959
references.citation: J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):192-7
references.pmid: 3624557
references.citation: Expert Rev Respir Med. 2011 Jun;5(3):353-61
references.pmid: 21702658
references.citation: Acta Derm Venereol. 1996 Sep;76(5):385-6
references.pmid: 8891014
references.citation: Chem Biol. 2012 Jan 27;19(1):99-115
references.pmid: 22284358
references.citation: Jpn J Clin Oncol. 2010 Feb;40(2):163-5
references.pmid: 19797416
references.citation: Anticancer Drugs. 1995 Apr;6(2):324-6
references.pmid: 7795280
references.citation: Met Based Drugs. 2010;2010:
references.pmid: 20886011
references.citation: Jpn J Clin Oncol. 1999 Nov;29(11):562-70
references.pmid: 10678560
references.citation: Hematology Am Soc Hematol Educ Program. 2009;:73-9
references.pmid: 20008184
references.citation: Ann Oncol. 2003 Mar;14(3):497-8
references.pmid: 12598359
references.citation: Contact Dermatitis. 2000 Feb;42(2):74-6
references.pmid: 10703627
references.citation: J Clin Oncol. 2010 May 20;28(15):2549-55
references.pmid: 20406923
references.citation: N Engl J Med. 1984 Feb 9;310(6):389
references.pmid: 6690968
references.citation: BMC Biol. 2011 Oct 28;9:73
references.pmid: 22034875
references.citation: J Support Oncol. 2010 Jul-Aug;8(4):149-61
references.pmid: 20822032
references.citation: Leuk Lymphoma. 2000 Mar;37(1-2):125-30
references.pmid: 10721776
references.citation: Oncologist. 2004;9(3):271-81
references.pmid: 15169982
references.citation: Br J Haematol. 2007 Mar;136(6):800-5
references.pmid: 17341265
references.citation: Arch Pathol Lab Med. 2012 Oct;136(10):1201-4
references.pmid: 23020724
references.citation: Monogr Allergy. 1990;28:1-10
references.pmid: 2259346
references.citation: Ann Oncol. 2000 Apr;11(4):497
references.pmid: 10847475
references.citation: Curr Opin Genet Dev. 2005 Feb;15(1):102-11
references.pmid: 15661540
references.citation: Cancer Res. 2004 Oct 1;64(19):6845-8
references.pmid: 15466170
references.citation: Science. 2010 Apr 9;328(5975):240-3
references.pmid: 20378816
references.citation: Arch Dermatol. 1982 Apr;118(4):263-6
references.pmid: 6950689
references.citation: J Hematol Oncol. 2009 Oct 27;2:45
references.pmid: 19860903
references.citation: Int J Gynecol Cancer. 2009 Oct;19(7):1284-7
references.pmid: 19823066
references.citation: J Dtsch Dermatol Ges. 2010 Sep;8(9):652-61
references.pmid: 20482685
references.citation: Anaesth Intensive Care. 2012 Mar;40(2):216-35
references.pmid: 22417016
references.citation: J Clin Oncol. 2002 Feb 15;20(4):1146-7
references.pmid: 11844841
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11393-8
references.pmid: 12177445
references.citation: N Engl J Med. 2008 May 8;358(19):2039-49
references.pmid: 18463380
references.citation: J Clin Oncol. 2003 Dec 15;21(24):4611-4
references.pmid: 14673050
references.citation: J Clin Pathol. 2009 Jun;62(6):481-92
references.pmid: 19474352
references.citation: Lancet. 2000 Nov 11;356(9242):1667-71
references.pmid: 11089838
references.citation: Semin Oncol. 1992 Oct;19(5):458-77
references.pmid: 1384149
references.citation: Ann Oncol. 1992 Sep;3(8):605-10
references.pmid: 1450041
references.citation: N Engl J Med. 2011 May 12;364(19):1844-54
references.pmid: 21561350
references.citation: Med Pediatr Oncol. 1997 Sep;29(3):226-7
references.pmid: 9212851
references.citation: Anticancer Agents Med Chem. 2010 Dec;10(10):753-68
references.pmid: 21269250
references.citation: Clin Lung Cancer. 2002 Jul;4(1):52-6
references.pmid: 14653877
references.citation: J Eur Acad Dermatol Venereol. 2011 May;25(5):596-8
references.pmid: 21492245
references.citation: Br J Dermatol. 2006 Nov;155(5):869-75
references.pmid: 17034512
references.citation: J Clin Invest. 2012 May;122(5):1832-48
references.pmid: 22484816
references.citation: Br Med J (Clin Res Ed). 1982 May 15;284(6327):1432-4
references.pmid: 6805553
references.citation: Clin Chest Med. 2004 Mar;25(1):53-64
references.pmid: 15062597
references.citation: Blood Rev. 2010 Nov;24 Suppl 1:S13-9
references.pmid: 21126632
references.citation: Arch Dermatol. 1996 Mar;132(3):272-6
references.pmid: 8607630
references.citation: Nat Rev Drug Discov. 2005 Jun;4(6):489-99
references.pmid: 15931258
references.citation: Acta Anaesthesiol Scand. 2009 Sep;53(8):1006-11
references.pmid: 19572931
references.citation: AJR Am J Roentgenol. 2000 Oct;175(4):1019-24
references.pmid: 11000156
references.citation: J Urol. 1987 Jul;138(1):143-4
references.pmid: 3110433
references.citation: Chest. 1994 Feb;105(2):634-6
references.pmid: 8306788
references.citation: Can Respir J. 2000 Nov-Dec;7(6):491-5
references.pmid: 11121094
references.citation: Eur J Clin Pharmacol. 2009 Oct;65(10):1057-9
references.pmid: 19521695
references.citation: J Allergy Clin Immunol. 2008 Sep;122(3):574-80
references.pmid: 18502492
references.citation: Toxicol Sci. 2010 Jun;115(2):307-21
references.pmid: 20071422
references.citation: Transfus Med Rev. 1993 Oct;7(4):268-74
references.pmid: 8241615
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2521-7
references.pmid: 21576646
references.citation: Lancet. 2000 Oct 7;356(9237):1255-9
references.pmid: 11072960
references.citation: Cancer Treat Rep. 1987 Feb;71(2):219-20
references.pmid: 3802121
references.citation: Cell Death Differ. 2008 Apr;15(4):678-85
references.pmid: 18259193
references.citation: J Clin Gastroenterol. 1999 Jun;28(4):341-4
references.pmid: 10372932
references.citation: Ann Hepatol. 2007 Jul-Sep;6(3):186-9
references.pmid: 17786148
references.citation: Leuk Lymphoma. 2005 Dec;46(12):1807-11
references.pmid: 16263585
references.citation: Front Biosci. 2006 Jan 01;11:479-91
references.pmid: 16146745
references.citation: Clin Cancer Res. 2009 Feb 15;15(4):1297-307
references.pmid: 19190131
references.citation: Carcinogenesis. 2000 Mar;21(3):505-15
references.pmid: 10688871
references.citation: Nat Rev Mol Cell Biol. 2003 Dec;4(12):915-25
references.pmid: 14685170
references.citation: Oncologist. 2007 May;12(5):610-21
references.pmid: 17522250
references.citation: J Pediatr Hematol Oncol. 2004 Nov;26(11):777-9
references.pmid: 15543019
references.citation: J Allergy Clin Immunol. 1976 Dec;58(6):691-712
references.pmid: 791988
references.citation: Eur J Haematol. 1997 Aug;59(2):124-5
references.pmid: 9293862
references.citation: Arch Dermatol. 1989 Nov;125(11):1512-7
references.pmid: 2684020
references.citation: Cell. 2007 Nov 2;131(3):463-75
references.pmid: 17981115
references.citation: Br J Cancer. 2003 Dec;89 Suppl 3:S16-22
references.pmid: 14661042
references.citation: Anesthesiology. 2003 Sep;99(3):536-45
references.pmid: 12960536
references.citation: Drug Saf. 2011 Dec 1;34(12):1151-60
references.pmid: 22077503
references.citation: J Biol Regul Homeost Agents. 2002 Apr-Jun;16(2):105-9
references.pmid: 12144121
references.citation: Clin Ther. 2009;31 Pt 2:2416-32
references.pmid: 20110050
references.citation: Am J Dermatopathol. 2005 Dec;27(6):504-28
references.pmid: 16314707
references.citation: Clin Breast Cancer. 2008 Jun;8(3):285-6
references.pmid: 18650161
references.citation: Rev Mal Respir. 1998 Apr;15(2):199-203
references.pmid: 9608992
references.citation: J Clin Oncol. 2001 Jun 15;19(12):3126-9
references.pmid: 11408510
references.citation: Br J Cancer. 2001 Feb 2;84(3):441
references.pmid: 11161414
references.citation: Clin Ter. 2001 Sep-Oct;152(5):319-21
references.pmid: 11794853
references.citation: J Clin Oncol. 1999 Apr;17(4):1141
references.pmid: 10561172
references.citation: Clin Cancer Res. 2011 Jun 1;17(11):3794-802
references.pmid: 21346148
references.citation: Arthritis Rheum. 2000 Feb;43(2):405-13
references.pmid: 10693882
references.citation: Hematology Am Soc Hematol Educ Program. 2004;:63-79
references.pmid: 15561677
references.citation: Curr Opin Drug Discov Devel. 2005 Jan;8(1):38-43
references.pmid: 15679170
references.citation: Cancer. 1980 May 1;45(9):2249-51
references.pmid: 6155201
references.citation: Blood. 2010 Sep 23;116(12):2127-33
references.pmid: 20530792
references.citation: Br J Dermatol. 2007 Sep;157(3):433-40
references.pmid: 17553039
references.citation: Ann Pharmacother. 2002 Dec;36(12):1897-9
references.pmid: 12452753
references.citation: Am J Clin Oncol. 1995 Jun;18(3):245-50
references.pmid: 7747713
references.citation: Open Respir Med J. 2012;6:63-74
references.pmid: 22896776
references.citation: Allergy. 2001 Sep;56(9):813-24
references.pmid: 11551246
references.citation: Adv Cancer Res. 2012;114:237-67
references.pmid: 22588059
references.citation: Gynecol Oncol. 2004 Nov;95(2):370-6
references.pmid: 15491759